Clearmind Medicine Inc. (CMND) P/B ratio

P/B ratio today
0.0×

Clearmind Medicine Inc. (CMND) trades at 0.0× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (October 31, 2025) its P/B ratio was 27.1×. That is 144.7% higher than the 11.1× of fiscal 2024. Figures as of 18 Nov 2026, 12:48 UTC, from Yahoo Finance.

Key facts

P/B ratio today
0.0×
P/B ratio, fiscal 2025
27.1×
Change on fiscal 2024
+144.7%
Highest on record
27.1×fiscal 2025
Lowest on record
11.1×fiscal 2024
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Clearmind Medicine Inc. P/B ratio, in more detail

Today's figure is 99.9% below the fiscal 2025 year-end.

Across the 3 fiscal year-ends on record (2023–2025), the highest was 27.1× in fiscal 2025 and the lowest 11.1× in fiscal 2024. Today's P/B ratio is at or below every one of the 3 fiscal year-ends on record; their median is 18.1×.

History · 3 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Clearmind Medicine Inc. P/B ratio, year by year

Clearmind Medicine Inc. (CMND) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today0.0×—$3.45—
202527.1× 144.7% up$2,547.20$93.84
202411.1× 38.6% down$4,448.00$400.97
202318.1×—$11,712.00$647.87
2022———-$10,146.77

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on CMND

Clearmind Medicine Inc., figure by figure

Clearmind Medicine Inc. (CMND) overview: price, valuation and scorecard

Clearmind Medicine Inc. P/B ratio: questions and answers

What is Clearmind Medicine Inc.'s P/B ratio?

Clearmind Medicine Inc. (CMND) trades at 0.0× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (October 31, 2025) its P/B ratio was 27.1×. That is 144.7% higher than the 11.1× of fiscal 2024.

Is Clearmind Medicine Inc.'s P/B ratio high or low compared with its own history?

Today's P/B ratio is at or below every one of the 3 fiscal year-ends on record; their median is 18.1×.

What are the highest and lowest P/B ratio figures on record for Clearmind Medicine Inc.?

Across the 3 fiscal year-ends on record (2023–2025), the highest was 27.1× in fiscal 2025 and the lowest 11.1× in fiscal 2024.

How is Clearmind Medicine Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Clearmind Medicine Inc. it is on record here for 3 fiscal years, 2023 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Clearmind Medicine Inc. (CMND) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CMND/pb-ratio

Underlying data: Yahoo Finance.